American Stock Exchange to Trade Options on Ten Securities NEW YORK, Feb. 11 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Thursday, February 12, 2004 on the New York Stock Exchange and Nasdaq Stock Market listed stocks of: * Autoliv, Inc. (Symbol: ALV) * ChipMOS TECHNOLOGIES (Bermuda) LTD. (Option Symbol: GMQ/Stock Symbol: IMOS) * Encysive Pharmaceuticals Inc. (Option Symbol: IQE /Stock Symbol: ENCY * Genome Therapeutics Corporation (Option Symbol: GUA/Stock Symbol: GENE) * Global Crossing Ltd. (Option Symbol: GQC/Stock Symbol: GLBC) * Keryx Biopharmaceuticals, Inc. (Option Symbol: QKY/Stock Symbol: KERX) * NII Holdings Inc. (Option Symbol: QHQ/Stock Symbol: NIHD) * Novavax, Inc. (Option Symbol: QUX/Stock Symbol: NVAX) * OpenTV Corp. (Option Symbol: IQO/ Stock Symbol: OPTV) * Pharmacopeia, Inc. (Option Symbol: ICQ/ Stock Symbol: PCOP) Autoliv, Inc. options will open with strike prices of 40 - 45 - 50 and position limits of 22,500 contracts. The options will trade on the January expiration cycle with initial expirations in March, April, July and October. The specialist will be Susquehanna Investment Group. Autoliv, Inc. develops and manufactures automotive safety systems for automotive manufacturers. ChipMOS TECHNOLOGIES (Bermuda) LTD. options will open with strike prices of 10 - 12 1/2 - 15 and position limits of 31,500 contracts. The options will trade on the March expiration cycle with initial expirations in February, March, June and September. The specialist will be Bowery Specialist Group, LLC. ChipMOS TECHNOLOGIES (Bermuda) LTD. provides semiconductor testing and assembly services to customers in Taiwan, Japan and the United States. EncysivePharmaceuticals Inc. options will open with strike prices of 7 1/2 - 10 - 12 1/2 and position limits of 31,500 contracts. The options will trade on the January expiration cycle with initial expirations in March, April, July and October. The specialist will be Tanstaafl Research & Trading, LLC. Encysive Pharmaceuticals Inc. discovers, develops and commercializes novel drugs, focusing on small molecule drug development and vascular biology. Genome Therapeutics Corporation. options will open with strike prices of 2 1/2 - 5 - 7 1/2 and position limits of 31,500 contracts. The options will trade on the March expiration cycle with initial expirations in February, March, June and September. The specialist will be Tanstaafl Research & Trading, LLC. Genome Therapeutics Corporation is a biopharmaceutical company focused on discovery and development of pharmaceutical products for specialty markets. Global Crossing Ltd. options will open with strike prices of 25 - 30 - 35 and position limits of 13,500 contracts. The options will trade on the March expiration cycle with initial expirations in February, March, June and September. The specialist will be LaBranche Structured Products, LLC. Global Crossing Ltd. provides telecommunications solutions over a global Internet protocol-based network, which reaches various countries around the world. Keryx Biopharmaceuticals, Inc. options will open with strike prices of 7 1/2 - 10 - 12 1/2 and position limits of 22,500 contracts. The options will trade on the March expiration cycle with initial expirations in February, March, June and September. The specialist will be AGS Specialists LLC. Keryx Biopharmaceuticals, Inc. applies data from the human genome for the systematic discovery of new drugs. NII Holdings Inc. options will open with strike prices of 90 - 95 - 100 and position limits of 31,500 contracts. The options will trade on the March expiration cycle with initial expirations in February, March, June and September. The specialist will be TD Options, LLC. NII Holdings Inc. provides mobile communications for business customers in Latin America. Novavax, Inc. options will open with strike prices of 5 - 7 1/2 - 10 and position limits of 22,500 contracts. The options will trade on the January expiration cycle with initial expirations in March, April, July and October. The specialist will be Charlton Specialist Partners LLC. Novavax, Inc., a biopharmaceutical company, researches and develops proprietary topical and oral drug delivery technologies. OpenTV Corp options will open with strike prices of 2 1/2 - 5 - 7 1/2 and position limits of 75,000 contracts. The options will trade on the January expiration cycle with initial expirations in March, April, July and October. The specialist will be Bowery Specialist Group, LLC. OpenTV Corp. provides software that enables digital interactive television. Pharmacopeia, Inc. options will open with strike prices of 15 - 17 1/2 - 20 and position limits of 13,500 contracts. The options willtrade on the January expiration cycle with initial expirations in March, April, July and October. The specialist will be AGS Specialists LLC. Pharmacopeia, Inc. provides technology-based services that accelerate drug discovery and chemical development. The American Stock Exchange(R) (Amex(R)) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a nationalequities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 138 ETFs to date. The Amex is also one of the largest options exchanges inthe U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. DATASOURCE: American Stock Exchange CONTACT: Lynn Teresky of the American Stock Exchange, +1-212-306-1654, Web site: http://www.amex.com/

Copyright